Boehringer Ingelheim Pharma GmbH & Co. KG (manufacturing, primary and secondary packaging, labeling, quality control, including stability studies and batch release)
UkraineAll medications by this manufacturer
-
Mirapex® pd
Form: tablets, extended-release
Active substance Dosage pramipexole 0.26 mg ATC: N04BC05
-
Mirapex® pd
Form: tablets, extended-release
Active substance Dosage pramipexole 0.52 mg ATC: N04BC05
-
Mirapex® pd
Form: tablets, extended-release
Active substance Dosage pramipexole 1.05 mg ATC: N04BC05